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The organ shortage has led to extend the procurement to
kidneys from ‘marginal’ donors. As a result, an increasing
number of kidneys are discarded, but an extended analysis
of the validity of the clinical decision to accept or decline
a marginal graft remains to be determined. We have
retrospectively analyzed the outcome of 170 kidney
transplantations, performed in eight renal transplantation
centers between 1992 and 1998. Study group included
transplantation from donors accepted after refusal for poor
donor or graft quality by at least two centers. Control group
included 170 paired recipients from kidneys unanimously
accepted by all centers. Main causes of kidney refusal
included impaired donor hemodynamics (28%), abnormal
pre-harvesting serum creatinine (22%), advanced age in
donors (15%), and donor atheroma (14%). The 5-year patient
survival (88.2% in the study group and 88.9% in controls) and
graft survival (70.4% in the study group and 76.7% in
controls, P¼ 0.129) were not significantly different. Delayed
graft function occurred significantly more often in the study
group patients than in controls patients (63 vs 32%,
Po0.0001). Primary non-functioning kidneys were
significantly more frequently observed in study patients than
in controls (7.7 vs 1.8%, P¼ 0.01). Mean creatinine clearance
was significantly lower in the study group patients compared
with controls during the post-transplant course. Our results
suggest that these initially discarded kidneys provide
satisfactory survival rates despite their impaired early
functional recovery and poorer long-term renal function,
and therefore might be considered acceptable for
transplantation in the context of organ shortage.
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Over the last 15 years, the limited supply of cadaver donors for
renal transplantation led to consider alternative strategies for
making more organs available.1 One of them is the expansion
of the cadaveric kidney donor pool to include those who
might have been deemed unsuitable in early times, the use of
organs from older donors emerging as the most obvious
option.2 In parallel, global donor characteristics were chang-
ing with an increasing number of elderly donors with
a history of hypertension and diabetes, deceased because of
stroke or other cardiovascular causes.3 This led in the early
1990s to the concept of ‘marginal’ donors4 and, more recently,
to the notion of ‘expanded criteria donors’, defined by the
United Network for Organ Sharing as those donors who,
because of extremes of age or other clinical characteristics, are
expected to produce allografts at risk for diminished post-
transplant function.5,6 However, clinical investigations attempt-
ing to clearly delineate the procurement selection and graft
acceptance criteria as to assess the donor risk factors for graft
and patient outcomes have yielded conflicting results and there
is currently neither universal nor unequivocal definition of
what constitutes a ‘marginal’ transplantable kidney.
Thus, it is left to the transplant center to determine on the
basis of available information whether to accept or decline
these kidneys. As a result of the use of expanded criteria
donor organs, an increasing number of kidneys are discarded
and never transplanted, contributing to the stagnation of the
transplantation activity. United Network for Organ Sharing
reported7 an increase in the number of organs procured but
not transplanted from 5.3 to 13% between 1991 and 2000,
70% of them being discarded because of concerns regarding
donor or graft quality, based on clinical or histological data.
An accurate analysis of the causes of graft refusal by
transplant centers remains to be performed. According to
United Network for Organ Sharing criteria’s,5 32.5% of the
kidneys transplanted in the French regional area of Ile de France
during 2004 came from expanded criteria donors (unpublished
data). This indicates that such criteria’s are in fact poorly
selective for graft acceptance. It is of concern the validity of the
clinical decision to accept or decline a previously discarded renal
transplant, because no control study regarding the outcome of
such grafts that are subsequently transplanted are yet available.
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The present retrospective case-controlled multicenter
study was designed to compare the fate of transplants
performed with kidneys, defined by their secondary accep-
tance by centers after primary refusal by two or more other
transplant centers, to the outcome of transplantation
performed with ‘optimal kidneys’ directly accepted by
centers. The aims were not to propose a new definition of
expanded criteria donors but, from an operational point of
view, to analyze retrospectively the causes of kidney refusal
and to determine whether the local center’s concerns about
inferior graft function and increased morbidity and mortality
in the recipient are justified.
RESULTS
Analysis of kidney refusals
One hundred and seventy patients from the study group
received a kidney procured from 111 ‘marginal’ donors.
Thus, 52 kidneys were discarded by all transplant centers and
never transplanted.
The analyses of the main causes of kidney refusal are listed
in Table 1. Thirty-two proposals (28%) were refused because
of impaired donor hemodynamics (severe hypotension,
prolonged cardiac arrest, or prolonged anuria) during the
pre-harvesting period. The second most frequently alleged
reason for refusal was abnormal pre-harvesting serum
creatinine in 24 donors (22%). Advanced age was recorded
in 17 donors (15%). Other causes included donor atheroma
in 15 donors (14%), miscellaneous medical history (includ-
ing donor’s history of hypertension or diabetes) in seven
donors (6%), anatomic abnormalities in eight donors (7%),
abnormal microscopic characteristics in four donors (4%)
and prolonged ischemia in four donors (4%). Finally,
according to graft refusal criteria, patients could be separated
in two groups: group ‘acute’ (n¼ 92, 54%) included patients
who received grafts initially refused on the basis of ‘acute’
criteria occurring just before donation (impaired donor
hemodynamics, abnormal initial serum creatinine and
prolonged ischemia time); group ‘chronic’ (n¼ 78, 46%)
included patients who received grafts initially refused on the
basis of ‘chronic’ criteria (advanced donor age, donor
atheroma, anatomic abnormalities, donor history of hyper-
tension and abnormal macroscopic characteristics).
Characteristics of the donors and the transplant recipients
Characteristics of the kidney recipients and their donors in
both groups are presented in Table 2. Donors in the study
group were significantly older than in the control group. The
analysis of causes of donors death in the study group showed
a significantly lower incidence of deaths from traumatic
and toxic causes, and an increased though nonsignificant
incidence of deaths from cerebrovascular causes. Cardiac
resuscitation and oligoanuria episodes were more frequently
observed in the study group. Finally, donor serum creatinine
was significantly higher in the patients of the study group.
Importantly, no statistical difference was found between
patients of both groups according to the recipient risk factors
such as pre-transplant immunization rate and human
leukocyte antigen matching. Mean cold ischemia times
(CIT) were not statistically different between both groups.
Analysis of early post-transplant kidney function and
complications (first 6 months)
We found an increased incidence of post-transplant compli-
cations in relation with impaired early renal function. A
significant number of early failures was recorded in patients
receiving a marginal kidney compared to controls receiving
an optimal kidney: 13 kidneys (7.7%) in the study group had
never functioned vs 3 (1.8%) (P¼ 0.01) in the controls. Post-
transplant anuria was recorded in 41 patients (24.1%) of the
study group and only in 22 in controls (12.9%), this
difference being statistically significant (P¼ 0.013). Conse-
quently, the incidence of delayed graft function was higher in
patients from the study group compared to controls: 63 vs
32%, Po0.0001. Finally, the mean length of post-transplant
initial hospitalization time was significantly longer in the
study group compared to control subjects: 34.9 vs 29.7 days
(P¼ 0.0039).
Patients of both groups received comparable immuno-
suppressive regimens. Induction with polyclonal antibodies
was given in half of patients (84/170 of study patients and 86/
170 controls). Calcineurin inhibitors were given in 145 study
patients (85%, including 140 receiving cyclosporine and five
tacrolimus) and 154 controls (91%, including 149 receiving
cyclosporine and five tacrolimus). The percentage of patients
receiving delayed postoperative anticalcineurin therapy was
not statistically significant in both groups: 59% in the study
group patients and 49% in controls.
The incidence of presumed acute rejection episodes was
not significantly different between the two groups and occurs
in 61 patients (35.9%) from the study group and in 52
patients from the controls (30.6%).
Table 1 | Main causes of graft refusals in the study group
Main cause of refusals Percentage
Impaired donor hemodynamics 28
Cardiac arrest 16
Anuria 8
Severe hypotension (collapses) 4
Abnormal serum creatininea 21
120oCr4200mmol/l 5
200oCr4400mmol/l 13.5
Cr4400mmol/l 2.5
Advanced donor age (years) 15
60–69 9
X70 6
Donor atheroma 14
Anatomic abnormalities 7
Donor history of hypertension 6
Prolonged ischemia time (432 h) 5
Abnormal macroscopic characteristics 4
aInitial pre-harvesting serum creatinine.
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Kaplan–Meier analysis of kidney and patient survival and
causes of graft failures
All patients were followed for at least 5 years. Figure 1 shows
graft and patient survivals up to 5 years post-transplant.
Patient survival was similar in both groups (88.2 and 88.9%
at 5 years in the study and the control group, respectively)
(Figure 1a). The 5-year graft survival was, respectively, 70.4
and 76.7 (Figure 1b) in the study and the control groups, but
the difference did not reach statistical significance (log-rank
test: w2¼ 2.294, P¼ 0.129). Death-censored graft survival at 5
years was also similar in the study and the control group
(79.3 and 85%, respectively, at 5 years, P¼ 0.19). According
to the ‘acute’ (group ‘acute’) and ‘chronic’ (group ‘Chronic’)
criteria, the 5-year graft survival was 73.5 and 76.9%,
respectively, in the ‘acute’ and the control groups (P¼ 0.79)
and 66.2 and 75.9%, respectively, in the ‘chronic’ and the
control groups (P¼ 0.09). As depicted in Figure 2, the
‘chronic’ parameter showed a tendency towards an inferior
graft survival compared to the acute parameter, although the
difference was not statistically significant (P¼ 0.19).
Fifty-nine patients from the study group either died or lost
their transplant, including 20 deaths and 39 graft failures.
Out of those 39 graft failures, chronic rejection was the cause
of failure in 16 patients, acute rejection in six, surgical
complications in two and miscellaneous causes in two.
The 13 remaining patients of the study group (22%) had
early graft failures, including six arterial thrombosis and
seven primary non-functioning kidney. The grafts from these
13 patients came from marginal donors with (i) donor age
460 years old in 11 cases, (ii) donor with primary
hypertension in eight cases, (iii) serum creatinine level
4200 mmol in four cases, and (iiii) prolonged ischemia time
(432 h) in three cases.
In the control group of ‘optimal’ kidney recipients, 47
patients either died or lost their transplant, including 18
deaths and 29 graft failures. Out of those 29 graft failures,
Table 2 | Characteristics of donors and recipients in both study and control (optimal kidneys) groups; study group included
graft refused on the basis of acute (A) or chronic (C) criteria
Characteristic Study group N=170 (A: 92, C: 78) Control group N=170 P-value
Mean donor age7s.d. (years) 50.2713.5 39.5712.6 o0.0001
(A: 46.277.5)
(C: 54716.3)
Donor cause of death
CVA/stroke 42.3% (A: 36.9%, C: 46.2%) 32.3% 0.006
Trauma 14.7% (A: 15.4%, C: 14.1%) 25.9% NS
Suicide 13% (A: 15.6%, C: 11.3%) 9% NS
Respiratory failure 11% (A: 11.3%, C: 10.9%) 7% NS
Infection (meningitis) 8% (A: 11.4%, C: 5.2%) 5% NS
Cardiac arrest 5% (A: 6%, C: 4.2%) 4% NS
Neurological tumor 3% (A: 3.8%, C: 2.2%) 4% NS
Toxic 2.9% (A: 3.1%, C: 2.7%) 12.9% 0.0007
Mean donor pre-harvesting serum creatinine7s.d. (mmol/l) 163786 98740 o0.0001
(A: 193797)
(C: 127736)
Donor episode of prolonged anuria
Yes 24.1% (A: 30%, C: 18%) 12.9% 0.0136
No 75.9% (A: 70%, C: 82%) 87.1%
Donor episode of cardiac resuscitation
Yes 38% (A: 45%, C: 32%) 18.2% o0.0001
No 62% (A: 55%, C: 68%) 81.8%
Donor episode of prolonged hypotension
Yes 21.2% (A: 25.2%, C: 18%) 26.5% NS
No 78.8% (A: 74.8%, C: 82%) 73.5%
Mean cold ischemia time7s.d. (h) 28.378 (A: 29.5710) (C: 27.277) 28.5710 NS
Mean recipient age at transplant7s.d. (years) 45.8712.4 42.5712.3 NS
NS
NS
(A: 44.9710)
(C: 47.1713)
Mean number of HLA mismatches (A-B-DR)7s.d. 2.971.1 2.871.1 NS
NS
NS
(A: 2.971)
(C: 2.971.5)
Peak PRA level (%)
0–4 77% (A: 80%, C: 74.8%) 69.4% NS
5–80 21.8% (A: 23.5, C: 20.2%) 25.3% NS
480 1.2% (A: 1.1%, C: 1.3%) 5.3% NS
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chronic rejection was the cause of failure in 13 patients, acute
rejection in six, surgical complications in one and mis-
cellaneous complications in six. In the control group, only
three early failures were recorded (6.3% of the total of
failures), including two cases of arterial thrombosis and one
primary non-functioning kidney. Causes of graft loss in both
groups are listed in Table 3.
Analysis of renal function
Overall, mean creatinine clearance during the follow-up
period (Figure 3) was significantly (Po0.001) lower in the
study group patients compared to controls from day 7. In
both groups, mean creatinine clearance progressively in-
creased in a parallel manner from day 2 to month 3: 40.2 ml/
min (95% confidence interval (CI) 36.9–43.6) in the study
group patients and 52.3 ml/min (95% CI 49.2–55.4) in the
controls had remained stable until 2 years post-transplant
and then started to decline: 33.3 ml/min (95% CI 29.5–38.1)
in the study group patients and 48.5 ml/min (95% CI
42.7–56.3) in the controls at 5 years. We also calculated mean
creatinine clearance in the groups refused on the basis of
acute and chronic injury at 5 years. The mean creatinine
clearance was significantly higher in the ‘acute’ group
compared with the ‘chronic’ group (38.9 ml/min, 96% CI
33.4–41.1 vs 28.5 ml/min, 95% CI 22.2–34.8) (P¼o0.001).
DISCUSSION
During the study period, 170 transplantations, representing
5.2% of the total of the kidney transplantation activity in Ile
de France, have been performed using grafts declined by two
or more centers. Those grafts were refused by individual
centers based on their assessment of the donors and grafts
qualities. Analysis of the principal causes of kidney refusal
reveals classical characteristics of marginal donor kidney
(donor age, abnormal serum creatinine, donor medical
history or prolonged ischemia time) but, interestingly, also
includes other factors that do not meet the previously
reported expanded donors’ criteria such as donor atheroma,
donor anatomic abnormalities and, chiefly, impaired donor
hemodynamics.6,8,9 This, however, accounts for real practice
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Figure 1 | Recipients of study and control kidney transplants have
similar graft and patient survival up to 5 years post-transplant.
Recipients of study and control grafts have similar patient and graft
survival up to 5 years post-transplant. Kaplan–Meier survival curves
between 0 to 5 years post-transplant are shown for, (a) patient
survival, (b) overall graft survival, and (c) death-censored graft
survival of patients from the study (solid lines) and the control group
(dashed lines). For all three survival indices, no significant differences
are present between the two groups (P¼NS).
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Figure 2 | Influence of the ‘acute’ and ‘chronic’ cause of graft
refusal on the 5-year graft survival. The ‘acute’ and ‘chronic’
parameters did not influence significantly graft survival up to 5 years
post-transplant (P¼ 0.19). Kaplan–Meier survival curves between 0
and 5 years post-transplant are shown for patients who received
organs refused on the basis of ‘acute’ criteria (dashed lines) or
‘chronic’ criteria (solid lines).
Table 3 | Causes of graft failure in the study and the control
group
Causes of graft failure
Study group
(n=39)
Control group
(n=29) P-value
PNFK 13 3 0.01
Chronic rejection 16 13 NS
Acute rejection 6 6 NS
Surgical complications 2 1 NS
Miscellaneous complications 2 6 NS
PNKF=primary non-functioning kidneys.
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of several transplant centers in France. The main causes of
kidney refusal as stated by each transplant center in the
Etablissement Francais des Greffes registry are listed in
Table 1. We cannot exclude that, in several cases, refusal was
indeed justified by more than a single criterion. For instance,
we report that in 15% of cases, cause of refusal was advanced
donors age and in 14%, donors atheroma. It is likely that
most patients from these subgroups are sharing both criteria.
The potentially important question, whether this assess-
ment was accurate or not, might be answered by evaluating
whether the utilization of these initially refused organs had a
negative impact on long-term post-transplant outcome.
Our study showed that acceptable long-term graft survival
(i.e. 70.4% at 5 years) was achieved using discarded kidneys.
The 170 recipients of optimal kidneys from the control group
had a 6.7% better 5-year graft survival rate compared with
the study patients, although this difference was not
statistically significant. Furthermore, transplantation of
kidneys from the study group was not associated with a
significantly increased mortality. Historical reports on
marginal kidney transplantation, essentially from elderly
donors, have shown that greater donor age was associated
with lower graft survival.9–11 In 2001, Ojo et al.8 reported a
significantly lower 5-year graft survival in a group of
marginal donor kidney recipients, compared with optimal
donor kidney recipients (53 and 67%, respectively). Further
analyses have suggested, however, that post-transplant out-
come of marginal kidneys was not necessarily poor, and
depended on several factors, including donor risk factors
associated with atherosclerosis, factors associated with the
allocation process, CIT and finally all parameters involved in
the post-transplant period, such as quality and timing of
immunosuppressive combination protocol, and occurrence
and severity of post-transplant rejection episodes.12–14 Our
data are in accordance with studies15,16 reporting acceptable
survival rates using kidneys that would otherwise be
discarded, or using kidneys from donors with established
risk factors such as age, hypertension history, or severe
histological damages.17,18
Graft survival was also analyzed according to the cause of
graft refusal (‘acute’ and ‘chronic’). Although the difference
did not reach statistical significance, the results suggest that
patients who received grafts discarded because of events
occurring just before donation (potentially reversible) have a
better graft survival than patients who received grafts with
(or probably with) chronic lesions. This tendency is
confirmed by the significantly higher mean serum creatinine
clearance in recipients of kidney initially refused on the basis
of acute criteria. This suggests that the influence of acute
renal dysfunction on the decision to accept or to decline a
marginal renal transplant should be minimized. In contrast,
marginal kidneys with possible chronic renal damage may
require specific evaluation and allocation before they can be
considered for transplantation. This includes a large
recommendation of renal biopsy before transplantation, the
use of the ‘old for old’ strategy for organs distribution in case
of elderly donors and recipients and the use of dual
transplants. Moreover, recipients should be more system-
atically informed before transplantation on the possible
inferior outcome of those kidneys.
The incidence of acute rejection was in fact high in both
groups (35.9 and 30.6% in the control and the study groups,
respectively), especially since half of the patients received
induction therapy. However, this study was conducted from
1992 to 1998, and at this time, diagnosis of acute rejection
was not systematically confirmed by renal biopsy, suggesting
that acute rejection diagnosis could be overestimated. We also
found that organs from the study group were significantly
associated with an increased risk of post-transplant anuria,
an increased incidence of delayed graft function, and a
relatively poorer graft function in the first 2 years post-
transplant in comparison with recipients of paired optimal
transplants. It is of importance that 13 transplants from the
study group experienced primary non-function compared to
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Figure 3 | Recipients of study donor kidney transplants have lower average serum creatinine clearance compared to recipients of
control donor kidney transplants. Serum creatinine clearances calculated by the Cockcroft and Gault formula are shown for recipients of
marginal (m) and control (’) kidney transplants. Results are shown between day 1 to months 60 and expressed as mean7s.d. Po0.01 for
marginal donor recipients (study group) vs control donor recipients (control group).
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three controls. These findings could not be attributed to a
bias in recipient selection, because all parameters known to
affect renal function recovery were matched in both groups.
Utilization of allografts from marginal donors has been
associated with inferior performance in a number of
reports.19,20 The achievement of improved utilization has
been attempted by the transplantation of selected marginal
kidneys in dual transplantation protocols.21–23 However,
there are currently no established guidelines to determine
in which case dual transplantation should be performed.
Various criteria and scoring systems have been proposed,24,25
but never validated in controlled studies. Therefore, this
policy remains to be evaluated in the long term, and
controlled studies should be designed in order to compare
dual procedure with transplantation of single marginal
kidneys. Lack of clear benefits provided by dual procedure
could strongly challenge the dual transplantation policy in
the context of graft scarcity. Our data support the utilization
of separate kidneys from marginal donors for transplanta-
tion, yielding comparable overall long-term survival to that
obtained by transplantation of optimal kidneys. Thus, the
undeniable increased risk of early complications should not
prevent the systematic use of kidneys from donors with risk
factors. As previously implemented by the Eurotransplant
allocation system of the ‘old for old’ strategy for organs
distribution, we suggest that in the context of organ shortage,
these ‘marginal’ kidneys should be preferentially attributed to
recipients with a significant decrease in life expectancy,
including old recipients and patients with compromised
access to transplantation.
An important issue is preventing additional injuries that
have been proven to enhance the deleterious effects of donor
risk factors, that is, prolonged ischemia time, immunological
injuries26,27 and the nephrotoxicity of immunosuppressive
drugs. Fifty percent of patients in our study received
induction protocols with delayed introduction of antic-
alcineurin drugs, and the acute rejection incidence was
lower in one-third of patients. On the other hand, because
of the lack of tailored policies for the allocation and
transplantation of kidneys from donors presenting with
criteria of poor quality, a relatively prolonged mean CIT
(428 h) was unfortunately recorded in both groups of
our study. This fact could be, in part, responsible for the
poor functional recovery in the study group. The imple-
mentation in the Eurotransplant allocation system of a short
ischemia time,28 and this latter policy should be encouraged.
However, data from the Collaborative Transplant Study29
showing that a very short CIT was associated with a worse
graft survival than donors kidney exposed to 7–36 h of CIT
indicates that the critical length of CIT is still far from being
established.
CONCLUSION
The main objective of our study was to evaluate the outcome
of kidney grafts, defined as marginal according to an
operational strategy, that is, the refusal by at least two
centers, and to validate or not the transplant centers’ attitude.
Our data showing an increased incidence of delayed graft
function and primary non-functioning kidney as well as
decreased mean creatinine clearance values retrospectively
confirm that our study group was indeed composed of
marginal kidneys and, therefore, strengthen primary clinical
evaluation. This study, however, demonstrates that such
discarded grafts can provide acceptable survival rates,
suggesting that in numerous situations, the decision to
refuse them may be unjustified and that marginal donor
kidneys should be more rigorously defined to minimize the
discard of transplantable kidneys. However, according to the
‘chronic’ or ‘acute’ origins of renal damage, our results
also suggest that a note of caution is needed before suggesting
the use of kidney from marginal donors with possible
chronic lesions.
MATERIALS AND METHODS
Patients
Between January 1992 and December 1998, 3 258 cadaveric renal
transplants were performed in eight transplant centers located in the
French regional area of Ile de France. We retrospectively selected for
this case-controlled study 170 patients (study Group) who have
received during this period a ‘marginal kidney’, and 170 paired
patients (control Group). A ‘marginal kidney’ was defined as a
kidney accepted for transplantation in a transplant center after
having been refused because of a perceived increased risk of poor
renal function by at least two other centers from the same regional
area. The decision of centers to accept or decline kidneys was made
on a case-by-case basis, taking into account the available informa-
tion, including donor’s medical history, cause of death, initial pre-
harvesting serum creatinine, urine output, hypotension and cardiac
arrest episodes, anatomy and the general aspect of the kidney and
other variables. In the course of the selection for the study group,
living donors, multiple organ transplants, pediatric recipients and
transplants performed after refusal for technical or logistical
meanings were excluded. We have also excluded kidneys that were
turned down because graft was believed not to be appropriate for a
specified potential recipient, for immunological or any other
reasons. The control group was formed by selecting the patients
who had undergone kidney transplantation immediately before or
after each study group patient at the same transplant center, with a
kidney that no center has refused.
Demographic, medical, monitoring and procurement data of the
donors, routine yearly follow-up, graft failure and patient death were
reported to the Registry of the Etablissement Franc¸ais des Greffes.
The following data were retrieved and compared between both
groups: donor age, cause of death, pre-harvesting serum creatinine,
episodes of severe hypotension and cardiac arrest, CIT, recipient
demographic characteristics, panel-reactive antibody level (0–4, 5–80
and 480%) and mean human leukocyte antigen mismatching. We
have also compared variables characterizing immediate functional
transplant outcome: incidence of delayed postoperative diuresis
(urine output lower than 500 ml/day during the first 24 h after
transplantation), incidence of delayed graft function defined by the
need for post-transplantation hemodialysis or peritoneal dialysis
during the first 7 days after transplantation, and the incidence of
primary non-functioning kidneys defined as graft that had never
functioned. We have also compared the following variables:
immunosuppressive protocol (immediate or delayed treatment with
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anticalcineurin drug, induction or not with polyclonal antiglobu-
lins), incidence of post-transplant acute rejection episodes and
duration of initial hospitalization. In most cases (85%), acute
rejection was documented by a renal biopsy. The renal function was
assessed in both groups by comparing creatinine clearance
calculated by the Cockcroft and Gault formula at days 1, 2, 7 and
15, 1 month, 3 and 6 months, and 1- and 5-year post-transplant,
respectively. Graft and patient survivals were assessed until 5-year
post-transplant.
Statistical analysis
All statistical analyses were performed using the SAS software
package version 8.1 (SAS Institute Inc., Cary, NC, USA). Data are
expressed as mean7s.d., unless indicated otherwise. Differences in
donors and recipients variables were evaluated using the unpaired
Student’s t-test for continuous variables and the w2 test for nominal
variables. Graft survival was defined as an alive patient with a
functioning graft, the end point being defined as either death or
graft failure. The Kaplan–Meier survival estimator was used to
determine graft and patient survival. A two-sided P-value of 0.05
was considered statistically significant, as dependent variable on
allograft survival.
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Appendix A1
The data reported here have been supplied by the following
kidney transplantation centers from the Groupe Coope´ratif
de Transplantation d’Ile de France (GCIF) (listed in
alphabetic order): Cre´teil – Hoˆpital Henri-Mondor (Dr
Dahmane, Pr Lang), Le Kremlin-Biceˆtre – Hoˆpital Biceˆtre
(Dr Hiesse, Pr Charpentier), Paris – Hoˆpital Europe´en
Georges Pompidou (Dr Antoine, Pr Glotz), Paris – Hoˆpital
Necker (Dr Morelon, Pr Kreis), Paris – Hoˆpital de la Pitie´ (Dr
Barrou, Pr Bitker), Paris – Hoˆpital Saint-Louis (Dr Bed-
rossian, Pr Legendre), Paris – Hoˆpital Tenon (Pr Rondeau, Pr
Sraer), Suresnes – Hoˆpital Foch (Dr Aubert, Dr Delahousse).
Donor’s data have been supplied by local procurement units,
and collected by the Service de Re´gulation et d’Appui of
Re´gion Ile-de-France – Centre – Les Antilles (Dr Claquin, Dr
Atinault).
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